Simpler Grants.gov #HT942526AZRPTrCA

Army and DHA Seek Clinical Research Proposals for Alzheimer's Transforming Care Award

The Department of the Army and Defense Health Agency are soliciting clinical research proposals for the FY26 Alzheimer's Research Program (AZRP) Transforming Care Award: - Government Buyer: - Department of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Defense Health Agency, Defense Health Agency Research and Development (DHA R&D), Defense Health Agency Contracting Activity (DHACA) - Scope of Work: - Clinical research and clinical trials focused on interventions, innovations, and solutions for dementia care in individuals with Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD), as well as their care partners - Excludes clinical trials solely testing pharmacological interventions and studies using animal models - Requires preliminary data and demonstration of community collaboration for research involving human subjects - Encourages leveraging existing cohorts and datasets, including those with individuals 65 years or younger - Career Initiation or Transition (CIT) Partnership Option available for collaborative partnerships - Funding and Awards: - Approximately $5.4 million in total funding - About three awards anticipated - Cost caps: $1.6 million for single Principal Investigator (PI), $1.9 million for CIT Partnership Option - Maximum period of performance is four years - No specific OEMs or commercial vendors are named, as this is a grant for research services rather than product procurement - Notable Requirements: - Community collaboration is mandatory - Preliminary data must be provided - Animal model studies and pharmacological-only trials are not eligible

Description

The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s). Clinical trials solely testing pharmacological interventions and studies using animal models are not allowed. Preliminary data and community collaboration for research enrolling human subjects are required. The program encourages leveraging existing cohorts/datasets and includes a Career Initiation or Transition (CIT) Partnership Option for collaborative partnerships.

View original listing